Shares of Genus plc (LON:GNS) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and three have issued a buy rating on the company.
Several research analysts have commented on the company. Liberum Capital reissued a “buy” rating on shares of Genus plc in a research report on Monday. Peel Hunt reissued a “buy” rating on shares of Genus plc in a research report on Thursday, June 1st. Numis Securities Ltd reissued a “hold” rating on shares of Genus plc in a research report on Tuesday, April 4th. N+1 Singer reaffirmed a “hold” rating on shares of Genus plc in a research report on Monday, April 3rd. Finally, Berenberg Bank initiated coverage on Genus plc in a research report on Thursday, March 23rd. They set a “hold” rating on the stock.
Genus plc (LON GNS) traded up 0.26% during midday trading on Tuesday, reaching GBX 1921.00. The company’s stock had a trading volume of 27,010 shares. The firm’s market cap is GBX 1.17 billion. The company has a 50 day moving average price of GBX 1,855.03 and a 200 day moving average price of GBX 1,791.99. Genus plc has a 1-year low of GBX 1,323.00 and a 1-year high of GBX 2,113.00.
About Genus plc
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.